Natural Products as Possible Vaccine Adjuvants for Infectious Diseases and Cancer

2019 ◽  
pp. 187-213
Author(s):  
Anna-Mari Reid ◽  
Namrita Lall
Author(s):  
Oyere Tanyi Ebob ◽  
Smith B. Babiaka ◽  
Fidele Ntie-Kang

AbstractFor the past 2 years, the coronavirus responsible for the COVID-19 infection has become a world pandemic, ruining the lives and economies of several nations in the world. This has scaled up research on the virus and the resulting infection with the goal of developing new vaccines and therapies. Natural products are known to be a rich source of lead compounds for drug discovery, including against infectious diseases caused by microbes (viruses, bacteria and fungi). In this review article, we conducted a literature survey aimed at identifying natural products with inhibitory concentrations against the coronaviruses or their target proteins, which lie below 10 µM. This led to the identification of 42 compounds belonging to the alkaloid, flavonoid, terpenoid, phenolic, xanthone and saponin classes. The cut off concentration of 10 µM was to limit the study to the most potent chemical entities, which could be developed into therapies against the viral infection to make a contribution towards limiting the spread of the disease.


2015 ◽  
Vol 2015 ◽  
pp. 1-16 ◽  
Author(s):  
Patrick Valere Tsouh Fokou ◽  
Alexander Kwadwo Nyarko ◽  
Regina Appiah-Opong ◽  
Lauve Rachel Tchokouaha Yamthe ◽  
Mark Ofosuhene ◽  
...  

Mycobacterium ulceransdisease has been a serious threat for people living in rural remote areas. Due to poverty or availability of traditional medicine these populations rely on herbal remedies. Currently, data on the anti-Mycobacterium ulceransactivity of plants, so far considered community-based knowledge, have been scientifically confirmed, concomitantly with some medicinal plants used to treat infectious diseases in general. Products derived from plants usually responsible for the biological properties may potentially controlMycobacterium ulceransdisease; numerous studies have aimed to describe the chemical composition of these plant antimicrobials. Thus, the present work provides the first compilation of medicinal plants that demonstrated inhibitory potential onMycobacterium ulcerans. This work shows that the natural products represent potential alternatives to standard therapies for use as curative medicine forMycobacterium ulceransdisease.


2015 ◽  
Vol 15 (2) ◽  
pp. 51 ◽  
Author(s):  
Sujin Lee ◽  
Minh Trang Nguyen

2014 ◽  
Vol 21 (3) ◽  
pp. 261-270 ◽  
Author(s):  
Shishir Kumar Gupta ◽  
Preety Bajwa ◽  
Rajib Deb ◽  
Madhan Mohan Chellappa ◽  
Sohini Dey

ABSTRACTChicken raised under commercial conditions are vulnerable to environmental exposure to a number of pathogens. Therefore, regular vaccination of the flock is an absolute requirement to prevent the occurrence of infectious diseases. To combat infectious diseases, vaccines require inclusion of effective adjuvants that promote enhanced protection and do not cause any undesired adverse reaction when administered to birds along with the vaccine. With this perspective in mind, there is an increased need for effective better vaccine adjuvants. Efforts are being made to enhance vaccine efficacy by the use of suitable adjuvants, particularly Toll-like receptor (TLR)-based adjuvants. TLRs are among the types of pattern recognition receptors (PRRs) that recognize conserved pathogen molecules. A number of studies have documented the effectiveness of flagellin as an adjuvant as well as its ability to promote cytokine production by a range of innate immune cells. This minireview summarizes our current understanding of flagellin action, its role in inducing cytokine response in chicken cells, and the potential use of flagellin as well as its combination with other TLR ligands as an adjuvant in chicken vaccines.


2020 ◽  
Vol 2 (2) ◽  
pp. 16-21
Author(s):  
Reh Malem Br Karo ◽  
Putranto Manalu ◽  
Jhon Patar Sinurat

Natural products can be used as an alternative in the treatment of various diseases such as infectious diseases due to the bioactive compounds contained therein. Moreover nowdays, there are many antibiotic resistance in the treatment of infectious diseases. Citrus maxima is one of the natural products. Citrus maxima have been used for many diseases in traditional medicine.The aim of this study was to investigate the antibacterial activity of flavonoid-rich fractions of citrus maxima peel extract. The bioactive compounds contained in  Citrus maxima peel were extracted by maceration method using 96% ethanol solvent. Fractionation was conducted using liquid-liquid extraction using a solvent of water and ethyl acetate obtained ethyl acetate fraction. In this fraction, the TLC test was carried out to confirm the presence of phenolic and flavonoid compounds. The antibacterial activity testing for ethyl acetate fraction  against S.aureus and E.coli was determined  by disk diffusion method with concentration of 25 ppm, 50 ppm, 75 ppm and 100 ppm. The ciprofloxacin and distilled water were used as positive and negative control, respectively. The result of this study showed that ethyl acetate fraction ( flavonoid-rich fractions) Of Citrus Maxima has potential as antibacterial for bacterial S.aureus and E.coli with medium inhibitory ability in all of concentration ranges. The highest inhibition zone for S.aureus  was found  at a concentration of 100 ppm while for E.coli was at a concentration of 75 ppm.


2003 ◽  
Vol 1 (3) ◽  
pp. 309-320 ◽  
Author(s):  
Manmohan Singh ◽  
Indresh Srivastava

2014 ◽  
Vol 15 (10) ◽  
pp. 973-981 ◽  
Author(s):  
Katsuhiko Takahashi ◽  
Taiki Shimizu ◽  
Keita Kosaka ◽  
Masafumi Hidaka ◽  
Chiyoko Uchida ◽  
...  

The peptidyl prolyl cis/trans isomerase Pin1, the human ortholog of yeast Ess1 specifically isomerizes peptide bindings of pSer/pThr-Pro residues in various proteins, and regulates the expression levels and functions of phosphorylated proteins. Activation of Pin1 is associated with pathology of a variety of diseases, such as cancer, Alzheimer’s disease, infectious diseases and so on. Therefore, regulatory compounds for Pin1 can be applied as a clinical medicine against these diseases. Many chemists have exerted themselves to synthesize the inhibitors based on the 3D structure of Pin1. We have screened for the inhibitors against Pin1 from the natural products including the functional foods. Here we review the Pin1-associated pathology and the known inhibitors identified from natural products. And we introduce the screening methods targeting Pin1 activity.


Vaccine ◽  
2011 ◽  
Vol 29 (38) ◽  
pp. 6464-6471 ◽  
Author(s):  
Jose Rey-Ladino ◽  
Allen G. Ross ◽  
Allan W. Cripps ◽  
Donald P. McManus ◽  
Ronald Quinn

Phytomedicine ◽  
2008 ◽  
Vol 15 (8) ◽  
pp. 639-652 ◽  
Author(s):  
Shanmugam Hemaiswarya ◽  
Anil Kumar Kruthiventi ◽  
Mukesh Doble

Sign in / Sign up

Export Citation Format

Share Document